Philip N. Edwards

763 total citations
25 papers, 588 citations indexed

About

Philip N. Edwards is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Philip N. Edwards has authored 25 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 10 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Philip N. Edwards's work include Biochemical and Molecular Research (5 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Synthesis of Organic Compounds (3 papers). Philip N. Edwards is often cited by papers focused on Biochemical and Molecular Research (5 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Synthesis of Organic Compounds (3 papers). Philip N. Edwards collaborates with scholars based in United Kingdom, France and Argentina. Philip N. Edwards's co-authors include Kenneth T. Douglas, G. Smith, Richard A. Bryce, I. K. Smith, Michael Dukes, Peter J. Taylor, Mohammed Jaffar, Abdul M Gbaj, Sally Freeman and William P. Morris and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical Journal and Annals of the New York Academy of Sciences.

In The Last Decade

Philip N. Edwards

24 papers receiving 556 citations

Peers

Philip N. Edwards
Robert B. McFadyen United States
Philip N. Edwards
Citations per year, relative to Philip N. Edwards Philip N. Edwards (= 1×) peers Robert B. McFadyen

Countries citing papers authored by Philip N. Edwards

Since Specialization
Citations

This map shows the geographic impact of Philip N. Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip N. Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip N. Edwards more than expected).

Fields of papers citing papers by Philip N. Edwards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip N. Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip N. Edwards. The network helps show where Philip N. Edwards may publish in the future.

Co-authorship network of co-authors of Philip N. Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Philip N. Edwards. A scholar is included among the top collaborators of Philip N. Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip N. Edwards. Philip N. Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neres, João, Mark L. Brewer, Horacio Botti, et al.. (2008). Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening. Bioorganic & Medicinal Chemistry Letters. 19(3). 589–596. 56 indexed citations
2.
Neres, João, Pascal Bonnet, Philip N. Edwards, et al.. (2006). Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase. Bioorganic & Medicinal Chemistry. 15(5). 2106–2119. 36 indexed citations
3.
Gbaj, Abdul M, Philip N. Edwards, Philip Reigan, et al.. (2006). Thymidine phosphorylase fromEscherichia coli: Tight-binding inhibitors as enzyme active-site titrants. Journal of Enzyme Inhibition and Medicinal Chemistry. 21(1). 69–73. 18 indexed citations
4.
Edwards, Philip N.. (2006). A kinetic, modeling and mechanistic re-analysis of thymidine phosphorylase and some related enzymes. Journal of Enzyme Inhibition and Medicinal Chemistry. 21(5). 483–518. 12 indexed citations
5.
Reigan, Philip, Philip N. Edwards, Abdul M Gbaj, et al.. (2004). Aminoimidazolylmethyluracil Analogues as Potent Inhibitors of Thymidine Phosphorylase and Their Bioreductive Nitroimidazolyl Prodrugs. Journal of Medicinal Chemistry. 48(2). 392–402. 43 indexed citations
6.
Cole, Christian, Philip Reigan, Abdul M Gbaj, et al.. (2002). Potential Tumor-Selective Nitroimidazolylmethyluracil Prodrug Derivatives:  Inhibitors of the Angiogenic Enzyme Thymidine Phosphorylase. Journal of Medicinal Chemistry. 46(2). 207–209. 40 indexed citations
7.
Franklin, Trevor, et al.. (2001). Inhibition of prolyl 4-hydroxylase in vitro and in vivo by members of a novel series of phenanthrolinones. Biochemical Journal. 353(2). 333–333. 31 indexed citations
8.
Franklin, Trevor, et al.. (2001). Inhibition of prolyl 4-hydroxylase in vitro and in vivo by members of a novel series of phenanthrolinones. Biochemical Journal. 353(2). 333–338. 31 indexed citations
9.
Westwood, Nicholas J., Timothy D. W. Claridge, Philip N. Edwards, & Christopher J. Schofield. (1997). Reversible acylation of elastase by γ-lactam analogues of β-lactam inhibitors. Bioorganic & Medicinal Chemistry Letters. 7(23). 2973–2978. 12 indexed citations
10.
Dukes, Michael, et al.. (1996). The preclinical pharmacology of “Arimidex” (Anastrozole; ZD1033) — a potent, selective aromatase inhibitor. The Journal of Steroid Biochemistry and Molecular Biology. 58(4). 439–445. 73 indexed citations
11.
Dowell, Robert I., et al.. (1993). 4-Methoxy-2-methyltetrahydropyrans: chiral leukotriene biosynthesis inhibitors, related to ICI D2138, which display enantioselectivity. Journal of Medicinal Chemistry. 36(2). 295–296. 11 indexed citations
12.
Bird, T. G. C., Pierrick Bruneau, Robert I. Dowell, et al.. (1993). Structure and activity relationships leading to the discovery of ICI D2138, a selective, potent and orally active inhibitor of 5-lipoxygenase.. PubMed. 6(1-3). 249–57. 6 indexed citations
13.
Dowell, Robert I., Philip N. Edwards, Stephen J. Foster, et al.. (1992). Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors. Journal of Medicinal Chemistry. 35(14). 2600–2609. 69 indexed citations
14.
Dowell, Robert I., Philip N. Edwards, Stephen J. Foster, et al.. (1992). ChemInform Abstract: Methoxytetrahydropyrans. A New Series of Selective and Orally Potent 5‐ Lipoxygenase Inhibitors.. ChemInform. 23(51). 7 indexed citations
16.
Greenhill, John V., et al.. (1985). Conformational and tautomeric studies of acylguanidines. Part 1. Synthesis, ultraviolet spectroscopy, tautomeric preference, and site of protonation in some model compounds. Journal of the Chemical Society Perkin Transactions 2. 1255–1255. 15 indexed citations
17.
Edwards, Philip N., et al.. (1970). DECALINS ‐ A NEW CLASS OF COMPOUNDS ACTIVE AGAINST INFLUENZA A VIRUSES. Annals of the New York Academy of Sciences. 173(1). 292–299. 4 indexed citations
18.
Leete, Edward, Shibnath Ghosal, & Philip N. Edwards. (1962). Biosynthesis of The Non-Tryptophan Derived Portion of Ajmaline. Journal of the American Chemical Society. 84(6). 1068–1069. 19 indexed citations
19.
Edwards, Philip N. & G. Smith. (1961). 287. Akuamma alkaloids. Part IV. The decomposition of akuammicine in methanol. Journal of the Chemical Society (Resumed). 1458–1458. 11 indexed citations
20.
Edwards, Philip N. & G. Smith. (1961). 28. Akuamma alkaloids. Part II. The structure of akuammicine. Journal of the Chemical Society (Resumed). 152–152. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026